Skip to content
Annalist
Companies Screener Compare Deal Lab Method Data Quality For AI agents

Bristol-Myers Squibb Company

BMY · NYSE · Health care, pharmaceuticals · United States · US GAAP · Fiscal year ends December

Latest report: Q3 FY2026, the quarter ended 30 September 2026, released 29 October 2026. Snapshot FY2026Q3_f8aaf445.

Overview

Revenue, quarter
+6.9% year on year
Pre-tax income, quarter
−18.6% year on year
Net income, quarter
−1.8% year on year
Diluted EPS, quarter
−2.8% year on year
Pre-tax margin, last 4 quarters
+5.9pp year on year
Return on equity, last 4 quarters
+10.2pp year on year

Select a figure to see the document it came from.

Key Findings

Findings for the latest quarter, with their history over earlier quarters.

  1. Revenue for the quarter ended 30 September 2026 was US$13.1 billion, 6.9% higher than in the same quarter a year earlier.

    Strengthenedin Q3 FY2026 · stated since Q2 FY20256.9% from 5.7% in Q2 FY2026
    Rule: Revenue against a year earlier · Sources 10-Q 2026-09
    History of this finding, 11 records
    1. Q3 FY2026 StrengthenedRevenue for the quarter ended 30 September 2026 was US$13.1 billion, 6.9% higher than in the same quarter a year earlier.Recorded from FY2026Q3_f8aaf445 · data update
    2. Q2 FY2026 StrengthenedRevenue for the quarter ended 30 June 2026 was US$13.0 billion, 5.7% higher than in the same quarter a year earlier.Reconstructed · data update
    3. Q1 FY2026 StrengthenedRevenue for the quarter ended 31 March 2026 was US$11.5 billion, 2.6% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q4 FY2025 WeakenedRevenue for the quarter ended 31 December 2025 was US$12.5 billion, 1.3% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q3 FY2025 StrengthenedRevenue for the quarter ended 30 September 2025 was US$12.2 billion, 2.8% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q2 FY2025 NewRevenue for the quarter ended 30 June 2025 was US$12.3 billion, 0.6% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q2 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    8. Q1 FY2025 NewRevenue for the quarter ended 31 March 2025 was US$11.2 billion, 5.6% lower than in the same quarter a year earlier.Reconstructed · data update
    9. Q1 FY2025 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    10. Q4 FY2024 ConfirmedRevenue for the quarter ended 31 December 2024 was US$12.3 billion, 7.5% higher than in the same quarter a year earlier.Reconstructed · data update
    11. Q3 FY2024 NewRevenue for the quarter ended 30 September 2024 was US$11.9 billion, 8.4% higher than in the same quarter a year earlier.Reconstructed · initial
  2. Net income attributable to the company was US$2.2 billion, 1.8% lower than in the same quarter a year earlier.

    Newin Q3 FY2026 · first stated
    Rule: Net income against a year earlier · Sources 10-Q 2026-09
    History of this finding, 13 records
    1. Q3 FY2026 NewNet income attributable to the company was US$2.2 billion, 1.8% lower than in the same quarter a year earlier.Recorded from FY2026Q3_f8aaf445 · data update
    2. Q3 FY2026 RetiredThe finding changed to lower than a year earlier.Recorded from FY2026Q3_f8aaf445 · data update
    3. Q2 FY2026 StrengthenedNet income attributable to the company was US$3.3 billion, 153.2% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q1 FY2026 WeakenedNet income attributable to the company was US$2.7 billion, 9.0% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q4 FY2025 StrengthenedNet income attributable to the company was US$1.1 billion, 1,409.7% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q3 FY2025 NewNet income attributable to the company was US$2.2 billion, 81.8% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q3 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    8. Q2 FY2025 NewNet income attributable to the company was US$1.3 billion, 22.0% lower than in the same quarter a year earlier.Reconstructed · data update
    9. Q2 FY2025 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    10. Q1 FY2025 NewNet income attributable to the company was US$2.5 billion, against a net loss of US$11.9 billion in the same quarter a year earlier.Reconstructed · data update
    11. Q1 FY2025 RetiredThe finding changed to a profit after a loss a year earlier.Reconstructed · data update
    12. Q4 FY2024 StrengthenedNet income attributable to the company was US$72 million, 95.9% lower than in the same quarter a year earlier.Reconstructed · data update
    13. Q3 FY2024 NewNet income attributable to the company was US$1.2 billion, 37.2% lower than in the same quarter a year earlier.Reconstructed · initial
  3. Return on equity over the last 4 quarters was 44.1%, against 33.8% a year earlier.

    Weakenedin Q3 FY2026 · stated since Q1 FY2025
    Rule: Return on equity against a year earlier · Sources 10-Q 2025-09, 10-Q 2026-09, 10-K 2025-12 and 3 more
    History of this finding, 10 records
    1. Q3 FY2026 WeakenedReturn on equity over the last 4 quarters was 44.1%, against 33.8% a year earlier.Recorded from FY2026Q3_f8aaf445 · data update
    2. Q2 FY2026 StrengthenedReturn on equity over the last 4 quarters was 46.7%, against 29.3% a year earlier.Reconstructed · data update
    3. Q1 FY2026 WeakenedReturn on equity over the last 4 quarters was 38.8%, against 32.0% a year earlier.Reconstructed · data update
    4. Q4 FY2025 StrengthenedReturn on equity over the last 4 quarters was 40.5%, against -39.1% a year earlier.Reconstructed · data update
    5. Q3 FY2025 StrengthenedReturn on equity over the last 4 quarters was 33.8%, against -31.5% a year earlier.Reconstructed · data update
    6. Q2 FY2025 WeakenedReturn on equity over the last 4 quarters was 29.3%, against -26.7% a year earlier.Reconstructed · data update
    7. Q1 FY2025 NewReturn on equity over the last 4 quarters was 32.0%, against -25.5% a year earlier.Reconstructed · data update
    8. Q1 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    9. Q4 FY2024 StrengthenedReturn on equity over the last 4 quarters was -39.1%, against 26.5% a year earlier.Reconstructed · data update
    10. Q3 FY2024 NewReturn on equity over the last 4 quarters was -31.5%, against 26.9% a year earlier.Reconstructed · initial
  4. Free cash flow over the last 4 quarters was US$9.3 billion, and operating cash flow was 1.2 times net income attributable to the company.

    Interpretation. Operating cash flow paid for all capital expenditure, and the rest is free for dividends, share buybacks or debt repayment.

    Weakenedin Q3 FY2026 · stated since Q3 FY2024
    Rule: Free cash flow · Sources 10-K 2025-12, 10-Q 2025-09, 10-Q 2026-03 and 2 more
    History of this finding, 9 records
    1. Q3 FY2026 WeakenedFree cash flow over the last 4 quarters was US$9.3 billion, and operating cash flow was 1.2 times net income attributable to the company.Recorded from FY2026Q3_f8aaf445 · data update
    2. Q2 FY2026 ConfirmedFree cash flow over the last 4 quarters was US$11.4 billion, and operating cash flow was 1.4 times net income attributable to the company.Reconstructed · data update
    3. Q1 FY2026 WeakenedFree cash flow over the last 4 quarters was US$11.9 billion, and operating cash flow was 1.8 times net income attributable to the company.Reconstructed · data update
    4. Q4 FY2025 WeakenedFree cash flow over the last 4 quarters was US$12.8 billion, and operating cash flow was 2.0 times net income attributable to the company.Reconstructed · data update
    5. Q3 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$15.3 billion, and operating cash flow was 2.8 times net income attributable to the company.Reconstructed · data update
    6. Q2 FY2025 StrengthenedFree cash flow over the last 4 quarters was US$14.6 billion, and operating cash flow was 3.1 times net income attributable to the company.Reconstructed · data update
    7. Q1 FY2025 WeakenedFree cash flow over the last 4 quarters was US$13.1 billion, and operating cash flow was 2.6 times net income attributable to the company.Reconstructed · data update
    8. Q4 FY2024 ConfirmedFree cash flow over the last 4 quarters was US$13.9 billion, and operating cash flow was -1.7 times net income attributable to the company.Reconstructed · data update
    9. Q3 FY2024 NewFree cash flow over the last 4 quarters was US$13.8 billion, and operating cash flow was -2.1 times net income attributable to the company.Reconstructed · initial
  5. Net debt was US$31.1 billion at 30 September 2026.

    Weakenedin Q3 FY2026 · stated since Q3 FY2024
    Rule: Net debt or net cash · Sources 10-Q 2026-09
    History of this finding, 9 records
    1. Q3 FY2026 WeakenedNet debt was US$31.1 billion at 30 September 2026.Recorded from FY2026Q3_f8aaf445 · data update
    2. Q2 FY2026 WeakenedNet debt was US$32.8 billion at 30 June 2026.Reconstructed · data update
    3. Q1 FY2026 ConfirmedNet debt was US$36.0 billion at 31 March 2026.Reconstructed · data update
    4. Q4 FY2025 ConfirmedNet debt was US$36.4 billion at 31 December 2025.Reconstructed · data update
    5. Q3 FY2025 WeakenedNet debt was US$36.7 billion at 30 September 2025.Reconstructed · data update
    6. Q2 FY2025 ConfirmedNet debt was US$40.1 billion at 30 June 2025.Reconstructed · data update
    7. Q1 FY2025 ConfirmedNet debt was US$41.3 billion at 31 March 2025.Reconstructed · data update
    8. Q4 FY2024 ConfirmedNet debt was US$40.6 billion at 31 December 2024.Reconstructed · data update
    9. Q3 FY2024 NewNet debt was US$42.5 billion at 30 September 2024.Reconstructed · initial

Records before Q3 FY2026 are reconstructed from the latest snapshot. Ledger: findings.json.

Credit, liquidity, earnings quality and score findings: Analysis.

Data

Source documents27 documents, latest Form 10-Q, period ended 30 September 2026List
DownloadsExcel workbook · JSON
SnapshotFY2026Q3_f8aaf445

Corporate Events

  1. Acquisitions paid in cash31 December 2024

    Paid US$21.8 billion in cash for business acquisitions in fiscal 2024, 22.9% of total assets at the start of the year.

    Source 10-K 2025-12

Earnings, Returns and Balance Sheet

Revenue

By quarter, US dollars

Income Before Income Taxes

By quarter, US dollars

Net Income Attributable to the Company

By quarter, US dollars

Margins

Last 4 quarters at each quarter end, per cent

Returns

Last 4 quarters, per cent

Free Cash Flow

Operating cash flow less capital expenditure, by quarter, US dollars

Net Debt

Total debt less cash and short-term investments, at quarter end, US dollars

Diluted Earnings per Share

By quarter, as reported

Financial Statements

Figures as filed. Select a figure for its source document and method; a small d marks a quarter derived from cumulative reports.

The statements are loading. They are also available as JSON and CSV.

Ratios

Select a ratio for its formula and the figures it uses, each with its document; (i) gives its definition.

The ratios are loading.

Source Documents

Documents of this snapshot, latest first.

DocumentDateId
Form 10-Q, period ended 30 September 202629 Oct 202610-Q:0000014272-26-000024
Form 10-Q, period ended 30 June 202630 Jul 202610-Q:0000014272-26-000020
Form 10-Q, period ended 31 March 202630 Apr 202610-Q:0000014272-26-000010
Form 10-K, period ended 31 December 202511 Feb 202610-K:0000014272-26-000004
Form 10-Q, period ended 30 September 202530 Oct 202510-Q:0000014272-25-000149
Form 10-Q, period ended 30 June 202531 Jul 202510-Q:0000014272-25-000131
Form 10-Q, period ended 31 March 202524 Apr 202510-Q:0000014272-25-000091
Form 10-K, period ended 31 December 202412 Feb 202510-K:0000014272-25-000039
Form 10-Q, period ended 30 September 202431 Oct 202410-Q:0000014272-24-000147
Form 10-Q, period ended 30 June 202426 Jul 202410-Q:0000014272-24-000123
Form 10-Q, period ended 31 March 202425 Apr 202410-Q:0000014272-24-000096
Form 10-K, period ended 31 December 202313 Feb 202410-K:0000014272-24-000044
Form 10-Q, period ended 30 September 202326 Oct 202310-Q:0000014272-23-000181
Form 10-Q, period ended 30 June 202327 Jul 202310-Q:0000014272-23-000152
Form 10-Q, period ended 31 March 202327 Apr 202310-Q:0000014272-23-000104
Form 10-K, period ended 31 December 202214 Feb 202310-K:0000014272-23-000046
Form 10-Q, period ended 30 September 202226 Oct 202210-Q:0000014272-22-000196
Form 10-Q, period ended 30 June 202227 Jul 202210-Q:0000014272-22-000166
Form 10-Q, period ended 31 March 202229 Apr 202210-Q:0000014272-22-000114
Form 10-K, period ended 31 December 20219 Feb 202210-K:0000014272-22-000051
Form 10-Q, period ended 30 September 202127 Oct 202110-Q:0000014272-21-000224
Form 10-Q, period ended 30 June 202128 Jul 202110-Q:0000014272-21-000186
Form 10-Q, period ended 31 March 202129 Apr 202110-Q:0000014272-21-000126
Form 10-K, period ended 31 December 202010 Feb 202110-K:0000014272-21-000066
Form 10-Q, period ended 30 September 20205 Nov 202010-Q:0000014272-20-000279
Form 10-Q, period ended 30 June 20206 Aug 202010-Q:0000014272-20-000229
Form 10-Q, period ended 31 March 20207 May 202010-Q:0000014272-20-000168

Checks

324313 of 324 checks passed, 11 warnings
Fiscal calendar70 passedFiscal years last 350 to 380 days, quarters 80 to 125 days, and each period starts on the day after the one before. Checked at error level.
Quarters and fiscal year150 of 151 passedThe 4 quarters of every item add up to its fiscal year, or a later filing restated the year. Checked at error level; a difference that a later report explains is a warning, which does not stop publication.
Research and development expense, FY2020: $11,143m against $10,048m
Reported quarters0 of 4 passedA quarter that a filing reports on its own agrees with the figures of the same filing. Checked at warning level.
Repurchases of common stock, Q3 FY2022: $701m against $585m
Amortisation of intangible assets, Q3 FY2024: $2,400m against $2,500m
Amortisation of intangible assets, Q3 FY2025: $867m against $900m
Amortisation of intangible assets, Q3 FY2026: $491m against $457m
Figures of another period0 of 1 passedA quarterly figure that equals the figure of a longer period is left out. Checked at warning level.
Interest paid, Q2 FY2021: $807m
Withheld values1 value withheldA value that contradicts the definition of its item, or that documents report in contradiction, is withheld. Checked at warning level.
Amortisation of intangible assets, Q1 FY2022: withheld, negative where the item cannot be negative
Filer identity1 passedThe documents are those of the company of this page. Checked at error level.
Balance sheet identity27 passedTotal assets equal total liabilities and equity at each balance sheet date. Checked at error level.
Balance sheet structure26 of 27 passedTotal assets equal liabilities, temporary equity and total equity. Checked at warning level.
31 Dec 2025: $90,038m against $90,039m
Lease liabilities6 passedLease payments due, less imputed interest, equal the lease liabilities. Checked at warning level.
Debt maturities0 of 3 passedThe debt maturity schedule adds up to the long-term debt. Checked at warning level.
31 Dec 2023: $10,300m against $39,526m
31 Dec 2024: $14,000m against $49,431m
31 Dec 2025: $8,844m against $44,827m
Quarters and 9 months14 passedThe 3 reported quarters of a fiscal year add up to the reported 9-month figure. Checked at error level.
Gross profit2 passedRevenue less cost of revenue equals reported gross profit. Checked at warning level.
Earnings per share6 passedNet income divided by average shares agrees with reported basic earnings per share. Checked at warning level.
Interest and debt6 passedInterest expense of a fiscal year is between 0.5% and 15% of the average total debt at its opening and closing dates, so that the debt captured carries the interest reported. Checked at warning level.
Primary statements5 passedEach key figure of the latest fiscal year is a line of the income statement, the balance sheet or the cash flow statement of the annual report. Checked at warning level.

Data Quality

How many values of this snapshot the checks prove, and how many Annalist derives, withholds and tracks as restated. Every company.

Values published1,698
Confirmed by other figures50.9%, 864 values
Confirmed by a second document0.0%, 0 values
Derived from reported figures19.4%, 329 values
Values withheld1
Restated figures tracked13
Changes compared on one basis0
Company lines mapped0 of 0 reviewed

Citation

Annalist, Bristol-Myers Squibb Company, snapshot bristol-myers-squibb/FY2026Q3_f8aaf445 (as of FY2026 Q3); <item label>, <period>; source <document id> (<document url>)

Snapshot FY2026Q3_f8aaf445 · dataset SHA-256 f8aaf4455f10c5b4ed6a4c815ac25544e1e513a0a8a02f0bc1156948092bf50b · findings rules 0.5

Data: info.json · dataset.json · validation.json · documents.json